Health Care & Life Sciences

CNO Financial looking to refinance bank loans

November 30, 2010
J.K. Wall
The Carmel-based life and health insurer says it has started discussions with a group of lenders about refinancing $652.1 million in debt.
More

Indiana medical students opt for specialties, not family practice

November 27, 2010
Scott Olson
Interest in primary care has fallen off markedly due partly to relatively low pay.
More

Health reform tripping up Indiana wellness incentiveRestricted Content

November 27, 2010
J.K. Wall
Federal health reform will trump an Indiana law that allows health insurers to offer steep discounts to employers with healthy workers and which institute aggressive wellness programs, but experts say other provisions will motivate small firms.
More

AHLRICHS: Turn health reform into pragmatic answersRestricted Content

November 27, 2010
Health reform entrepreneurship could brand Indiana as productive, healthy place for employers to operate.
More

MCGOWAN: Reform's grandfathering option requires close look

November 27, 2010
Hugh M. McGowan
Widely hailed provision of health care reform now raises host of questions.
More

Med school students share their stories

November 27, 2010
Scott Olson
Five students at Indiana University School of Medicine contemplate whether to opt for family practice or a specialty.
More

St. Francis-WellPoint deal is a sign of the timesRestricted Content

November 27, 2010
J.K. Wall
St. Francis, which operates three Indianapolis-area hospitals, and WellPoint, the giant health insurer, announced this month that they have agreed to jointly form an accountable care organization.
More

Study: Indianapolis high-priced hospital market

November 24, 2010
J.K. Wall
Indianapolis-area hospitals have negotiated reimbursement rates with private health insurers that are two and three times higher than those paid by the federal Medicare program, suggesting the hospitals have the upper hand over insurers, according to a new study.
More

Clarian grows market share to 40 percent

November 24, 2010
J.K. Wall
Clarian Health has been growing faster than its peers in the Indianapolis market the past five years and is now generating healthy margins, according to a report this month by Moody’s Investors Service.
More

St. Francis hospitals getting Franciscan Alliance name

November 22, 2010
J.K. Wall
The Mishawaka-based health system's move comes after months of consumer research—and six months after rival system Clarian Health said it would change its name to Indiana University Health.
More

Dow AgroSciences moves into new research facility

November 20, 2010
 IBJ Staff
The division of Dow Chemical has a 15-year lease with Indianapolis-based developer Browning Investments on the two-story building near West 96th Street.
More

Community, Westview hospitals in 'strategic alliance' talks

November 18, 2010
J.K. Wall
The form an alliance would take is not clear, but Westview looked for additional resources from city's four major hospital systems.
More

City approves Beckman Coulter tax abatement

November 17, 2010
The tax abatement is tied to an expansion in which the company plans to invest $18 million in its Indianapolis operations and add as many as 95 jobs in the next three years.
More

Lilly scores series of small victories

November 17, 2010
J.K. Wall
The Indianapolis-based drugmaker finally won FDA approval for its antidepressant Cymbalta to treat chronic pain and fended off a patent challenge to rising-star cancer drug Alimta, but got a ratings downgrade on its debt.
More

Q&A

November 17, 2010
J.K. Wall
Les Zwirn, executive director of Better Healthcare for Indiana, talked about his group’s progress on promoting community collaborations to improve health and reduce the cost of care in cities around Indiana. BHI is hosting its third health care summit of Indiana community leaders today at Second Presbyterian Church in Indianapolis.
More

Court upholds Lilly patent on cancer drug Alimta

November 16, 2010
 IBJ Staff and Associated Press
A U.S. District Court judge on Monday upheld Eli Lilly and Co.’s patent on the cancer drug Alimta, protecting the compound until July 2016. It was a welcome win after a difficult few months for Indianapolis-based Lilly, which is facing a wave of patent expirations in coming years.
More

Study: Arthritis drug co-developed by Lilly shows promise

November 12, 2010
 IBJ Staff and Bloomberg News
Lilly paid $90 million in 2009 to acquire the global rights to the treatment in a bid to beef up its pipeline of medications for autoimmune diseases.
More

Acquisition big step for Lilly Diagnostics

November 10, 2010
J.K. Wall
Eli Lilly and Co.’s $800 million acquisition of Avid Radiopharmaceuticals Inc. is the biggest step yet in the drugmaker’s attempt to add diagnostics to its product portfolio.
More

Nurse practitioners get some autonomy

November 10, 2010
J.K. Wall
Could nurse practitioners get a promotion in the medical field? At least one health insurer is treating them like doctors now.
More

Drugmaker restarts race to boost 'good' cholesterol

November 10, 2010
Bloomberg News
Merck & Co. is betting it can succeed where Pfizer Inc. failed, with a new type of drug to combat heart disease by raising good cholesterol levels. Indianapolis-based Eli Lilly and Co. is testing a similar pill.
More

Drama builds in suit over Hilbert mother-in-law's life policy

November 6, 2010
Kathleen McLaughlin
Businessman J.B. Carlson is in debt for $5.9 million, and he may have been the last person to see 74-year-old Suzy Tomlinson alive. Her $15 million life-insurance policy named him as the beneficiary.
More

Indiana life sciences upstarts tap health reform booty

November 6, 2010
 IBJ Staff
The federal legislation is roundly criticized at a BioCrossroads meeting, but some firms have found a silver lining.
More

Indiana health exchange may take page from Utah playbookRestricted Content

November 6, 2010
J.K. Wall
In Utah, employers can give each of their workers a specific amount of money to apply toward health insurance. The worker then can use that money to choose from the 66 plans in the health insurance exchange.
More

Lilly wins approval of antidepressant Cymbalta for pain

November 4, 2010
Bloomberg News
The Food and Drug Administration has cleared Cymbalta for musculoskeletal pain such as arthritis and chronic lower back conditions, which could mean another $500 million in annual sales for Lilly, an analyst estimates.
More

Seeking growth, Lilly dumps Singapore for China

November 3, 2010
J.K. Wall
After recently deciding to close a research center in Singapore, Indianapolis-based Eli Lilly and Co. has decided to open a diabetes research center in China in the second half of 2011, further ramping up the drugmaker's presence in the world's fastest-growing pharmaceutical market.
More
Page  << 61 62 63 64 65 66 67 68 69 70 >> pager
Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
thisissue1-092914.jpg 092914

Subscribe to IBJ
ADVERTISEMENT